Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
12
Frequently Asked Questions
What is Market Cap of Kiora Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kiora Pharmaceuticals Inc market cap is $9.27M.
What is the 52-week high for Kiora Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiora Pharmaceuticals Inc 52 week high is $4.18 as of September 13, 2025.
What is the 52-week low for Kiora Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kiora Pharmaceuticals Inc 52 week low is $2.25 as of September 13, 2025.
What is Kiora Pharmaceuticals Inc stock price today?
Kiora Pharmaceuticals Inc stock price today is $2.64.
What was Kiora Pharmaceuticals Inc stock price yesterday?
Kiora Pharmaceuticals Inc stock price yesterday was $2.70.
What is the PE ratio of Kiora Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kiora Pharmaceuticals Inc’s P/E ratio is -0.82.
What is the Price-to-Book ratio of Kiora Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kiora Pharmaceuticals Inc P/B ratio is 0.4190.
What is the 50-day moving average of Kiora Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kiora Pharmaceuticals Inc 50-day moving average is $2.78.
How many employess does Kiora Pharmaceuticals Inc has?
